Provides genetic testing services using next-generation sequencing and proprietary algorithms to detect hereditary diseases, cancer mutations, and genetic disorders. These tests enable early diagnosis, personalized treatment plans, and risk assessment, improving health outcomes for patients in prenatal, oncology, and chronic disease contexts.
Funding
$236M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AGFounders
Product
Problem
Many hereditary diseases, cancer mutations, and genetic disorders are difficult to detect early, hindering timely intervention and personalized treatment. Traditional diagnostic methods often lack the sensitivity and breadth needed for comprehensive genetic analysis.
Solution
Gene Solutions offers a suite of genetic testing services that leverage next-generation sequencing (NGS) and proprietary algorithms for comprehensive detection of hereditary diseases, cancer mutations, and genetic disorders. Their services span prenatal care, oncology, and chronic disease management, enabling early diagnosis and personalized treatment plans. Gene Solutions utilizes cell-free DNA analysis and operates CAP-accredited NGS laboratories, ensuring high accuracy and reliability. The company's tests empower healthcare professionals to make informed decisions, improving patient outcomes through proactive risk assessment and tailored therapeutic strategies.
Target Audience
The primary target audience includes healthcare providers such as obstetricians, oncologists, and general practitioners, as well as hospitals and diagnostic centers seeking advanced genetic testing solutions for their patients.
Features
- Comprehensive genetic testing services covering prenatal care, oncology, and chronic diseases
- Next-generation sequencing (NGS) technology for high-sensitivity mutation detection
- Proprietary algorithms for accurate data analysis and interpretation
- triSure NIPT: Non-invasive prenatal testing for screening genetic abnormalities in the fetus
- BabySure: Newborn screening test for early detection of genetic disorders
- SPOT-MAS: Early cancer detection through liquid biopsy
- OncoGS: Comprehensive genomic profiling for personalized cancer treatment
- K-TRACK: Monitoring minimal residual disease (MRD) in cancer patients
- GenCare Premium: Comprehensive screening for hereditary cancers and chronic diseases
- CAP-accredited NGS laboratories ensuring high-quality testing standards